Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Activity of pyrazinamide in the guinea pig model of tuberculosis.

× No keyword cloud information.

9 in total

1. [Activity of pyrazinamide against experimental tuberculosis].

Authors: F GRUMBACH
Journal: Ann Inst Pasteur (Paris) Date: 1958-06

2. The antituberculous activity of pyrazinamide in vitro and in the guinea pig.

Authors: W STEENKEN; E WOLINSKY
Journal: Am Rev Tuberc Date: 1954-08

3. Pharmacokinetics-pharmacodynamics of pyrazinamide in a novel in vitro model of tuberculosis for sterilizing effect: a paradigm for faster assessment of new antituberculosis drugs.

Authors: Tawanda Gumbo; Chandima S W Siyambalapitiyage Dona; Claudia Meek; Richard Leff
Journal: Antimicrob Agents Chemother Date: 2009-05-18 Impact factor: 5.191

4. Antimicrobial therapy of tuberculosis: justification for currently recommended treatment regimens.

Authors: Denis A Mitchison
Journal: Semin Respir Crit Care Med Date: 2004-06 Impact factor: 3.119

5. Controlled clinical trial of short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis.

Authors:
Journal: Lancet Date: 1972-05-20 Impact factor: 79.321

6. Sterilising action of pyrazinamide in models of dormant and rifampicin-tolerant Mycobacterium tuberculosis.

Authors: Y Hu; A R Coates; D A Mitchison
Journal: Int J Tuberc Lung Dis Date: 2006-03 Impact factor: 2.373

7. Moxifloxacin and gatifloxacin in an acid model of persistent Mycobacterium tuberculosis.

Authors: G Kubendiran; C N Paramasivan; S Sulochana; D A Mitchison
Journal: J Chemother Date: 2006-12 Impact factor: 1.714

8. Evaluation of standard chemotherapy in the guinea pig model of tuberculosis.

Authors: Diane J Ordway; Crystal A Shanley; Megan L Caraway; Eileen A Orme; Daniel S Bucy; Laurel Hascall-Dove; Marcela Henao-Tamayo; Marisa R Harton; Shaobin Shang; David Ackart; Susan L Kraft; Anne J Lenaerts; Randall J Basaraba; Ian M Orme
Journal: Antimicrob Agents Chemother Date: 2010-02-16 Impact factor: 5.191

9. Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days.

Authors: Amina Jindani; Caroline J Doré; Denis A Mitchison
Journal: Am J Respir Crit Care Med Date: 2003-01-06 Impact factor: 21.405

9 in total

1 in total

1. Impact of immunopathology on the antituberculous activity of pyrazinamide.

Authors: Landry Blanc; Jansy Passiflora Sarathy; Nadine Alvarez Cabrera; Paul O'Brien; Isabela Dias-Freedman; Marizel Mina; James Sacchettini; Radojka M Savic; Martin Gengenbacher; Brendan K Podell; Brendan Prideaux; Thomas Ioerger; Thomas Dick; Véronique Dartois
Journal: J Exp Med Date: 2018-07-17 Impact factor: 14.307

1 in total